{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:31:20Z","timestamp":1792071080512,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NWO (Dutch Research Council) Veni Fellowship","award":["09150161810102"],"award-info":[{"award-number":["09150161810102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46738-w","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T06:33:30Z","timestamp":1775111610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of tear fluid glutathione synthetase and glutathione levels with amyloid positivity"],"prefix":"10.1038","volume":"16","author":[{"given":"Nienke","family":"van de Sande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ward","family":"van Deuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willemijn J.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"den Braber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter Jelle","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans R. J.","family":"Verhey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Thach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank D.","family":"Verbraak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke H.","family":"Bouwman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy M.M.A.","family":"Nuijts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inez H. G. B.","family":"Ramakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carroll A. B.","family":"Webers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Gijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"5054","key":"46738_CR1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy, J. A. & Higgins, G. A. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256 (5054), 184\u2013185 (1992).","journal-title":"Science"},{"key":"46738_CR2","doi-asserted-by":"publisher","first-page":"117957352090739","DOI":"10.1177\/1179573520907397","volume":"12","author":"KG Yiannopoulou","year":"2020","unstructured":"Yiannopoulou, K. G. & Papageorgiou, S. G. Current and Future Treatments in Alzheimer Disease: An Update. J. Cent. Nerv. Syst. Dis. 12, 1179573520907397 (2020).","journal-title":"J. Cent. Nerv. Syst. Dis."},{"issue":"2","key":"46738_CR3","first-page":"e12465","volume":"10","author":"J Cummings","year":"2024","unstructured":"Cummings, J. et al. Alzheimer\u2019s disease drug development pipeline: 2024. Alzheimer\u2019s Dementia: Translational Res. Clin. Interventions. 10 (2), e12465 (2024).","journal-title":"Alzheimer\u2019s Dementia: Translational Res. Clin. Interventions"},{"issue":"10","key":"46738_CR4","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.medj.2024.08.004","volume":"5","author":"Y Hu","year":"2024","unstructured":"Hu, Y. et al. Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer\u2019s disease. Med 5 (10), 1206\u20131226 (2024).","journal-title":"Med"},{"issue":"3","key":"46738_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7 (3), 263\u2013269 (2011).","journal-title":"Alzheimers Dement."},{"issue":"4","key":"46738_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack, C. R. et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 14 (4), 535\u2013562 (2018).","journal-title":"Alzheimer\u2019s Dement."},{"issue":"3","key":"46738_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7 (3), 270\u2013279 (2011).","journal-title":"Alzheimers Dement."},{"issue":"8","key":"46738_CR8","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack, C. R. Jr. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 20 (8), 5143\u20135169 (2024).","journal-title":"Alzheimers Dement."},{"key":"46738_CR9","doi-asserted-by":"crossref","unstructured":"Ashton NJ, Zetterberg H. A blood test for Alzheimer\u2019s disease: a decade of progress and success. eBioMedicine. 2025;112.","DOI":"10.1016\/j.ebiom.2024.105545"},{"issue":"1","key":"46738_CR10","doi-asserted-by":"publisher","first-page":"10064","DOI":"10.1038\/s41598-021-89514-8","volume":"11","author":"F Bachhuber","year":"2021","unstructured":"Bachhuber, F., Huss, A., Senel, M. & Tumani, H. Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing. Sci. Rep. 11 (1), 10064 (2021).","journal-title":"Sci. Rep."},{"issue":"9","key":"46738_CR11","first-page":"1744","volume":"60","author":"M Gijs","year":"2019","unstructured":"Gijs, M., Nuijts, R. M., Ramakers, I., Verhey, F. & Webers, C. A. B. Differences in tear protein biomarkers between patients with Alzheimer\u2019s disease and controls. Investig. Ophthalmol. Vis. Sci. 60 (9), 1744 (2019).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"46738_CR12","doi-asserted-by":"publisher","first-page":"22675","DOI":"10.1038\/s41598-021-01993-x","volume":"11","author":"M Gijs","year":"2021","unstructured":"Gijs, M. et al. Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration. Sci. Rep. 11 (1), 22675 (2021).","journal-title":"Sci. Rep."},{"issue":"S24","key":"46738_CR13","doi-asserted-by":"publisher","first-page":"e083029","DOI":"10.1002\/alz.083029","volume":"19","author":"GD Molfetta","year":"2023","unstructured":"Molfetta, G. D. et al. The detection of phosphorylated tau in tear fluid. Alzheimer\u2019s Dement. 19 (S24), e083029 (2023).","journal-title":"Alzheimer\u2019s Dement."},{"key":"46738_CR14","doi-asserted-by":"crossref","unstructured":"Gharbiya, M. et al. Beta-Amyloid Peptide in Tears: An Early Diagnostic Marker of Alzheimer\u2019s Disease Correlated with Choroidal Thickness. Int. J. Mol. Sci. ;24(3). (2023).","DOI":"10.3390\/ijms24032590"},{"key":"46738_CR15","doi-asserted-by":"crossref","unstructured":"Takyar, A. et al. Tear Biomarkers as Indicators of Alzheimer\u2019s Disease. Alzheimers Dement. ;20(Suppl 2). (2024).","DOI":"10.1002\/alz.089809"},{"key":"46738_CR16","doi-asserted-by":"publisher","first-page":"106730","DOI":"10.1016\/j.nbd.2024.106730","volume":"203","author":"MM van der Thiel","year":"2024","unstructured":"van der Thiel, M. M. et al. Linking human cerebral and ocular waste clearance: Insights from tear fluid and ultra-high field MRI. Neurobiol. Dis. 203, 106730 (2024).","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"46738_CR17","doi-asserted-by":"publisher","first-page":"e0158000","DOI":"10.1371\/journal.pone.0158000","volume":"11","author":"G Kall\u00f3","year":"2016","unstructured":"Kall\u00f3, G. et al. Changes in the Chemical Barrier Composition of Tears in Alzheimer\u2019s Disease Reveal Potential Tear Diagnostic Biomarkers. PLoS One. 11 (6), e0158000 (2016).","journal-title":"PLoS One"},{"issue":"1","key":"46738_CR18","doi-asserted-by":"publisher","first-page":"15437","DOI":"10.1038\/s41598-019-51837-y","volume":"9","author":"A Kenny","year":"2019","unstructured":"Kenny, A. et al. Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer\u2019s disease. Sci. Rep. 9 (1), 15437 (2019).","journal-title":"Sci. Rep."},{"issue":"1","key":"46738_CR19","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.1038\/s41467-023-43995-5","volume":"14","author":"S Lee","year":"2023","unstructured":"Lee, S. et al. Amplified fluorogenic immunoassay for early diagnosis and monitoring of Alzheimer\u2019s disease from tear fluid. Nat. Commun. 14 (1), 8153 (2023).","journal-title":"Nat. Commun."},{"key":"46738_CR20","unstructured":"K\u00e4rkk\u00e4inen, V. et al. Tear fluid reflects the altered protein expressions of Alzheimer\u2019s disease patients in proteins involved in protein repair and clearance system or the regulation of cytoskeleton. J. Alzheimer\u2019s Disease 0(0):13872877241295315 ."},{"key":"46738_CR21","doi-asserted-by":"crossref","unstructured":"Jones, G. et al. Comparison of Different Mass Spectrometry Workflows for the Proteomic Analysis of Tear Fluid. Int. J. Mol. Sci. ;23(4). (2022).","DOI":"10.3390\/ijms23042307"},{"issue":"1","key":"46738_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12883-023-03335-y","volume":"23","author":"N van de Sande","year":"2023","unstructured":"van de Sande, N. et al. Tear biomarkers for Alzheimer\u2019s disease screening and diagnosis (the TearAD study): design and rationale of an observational longitudinal multicenter study. BMC Neurol. 23 (1), 293 (2023).","journal-title":"BMC Neurol."},{"issue":"6","key":"46738_CR23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen, F. et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 10 (6), 844\u2013852 (2014).","journal-title":"Alzheimers Dement."},{"key":"46738_CR24","doi-asserted-by":"crossref","unstructured":"Schmeetz, J. et al. International reporting guidelines for tear fluid research: A Delphi consensus. Cont. Lens Anterior Eye :102448. (2025).","DOI":"10.1016\/j.clae.2025.102448"},{"issue":"1","key":"46738_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3233\/JAD-132306","volume":"41","author":"WM van der Flier","year":"2014","unstructured":"van der Flier, W. M. et al. Optimizing patient care and research: the Amsterdam Dementia Cohort. J. Alzheimers Dis. 41 (1), 313\u2013327 (2014).","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"46738_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13195-018-0406-7","volume":"10","author":"E Konijnenberg","year":"2018","unstructured":"Konijnenberg, E. et al. The EMIF-AD PreclinAD study: study design and baseline cohort overview. Alzheimers Res. Ther. 10 (1), 75 (2018).","journal-title":"Alzheimers Res. Ther."},{"issue":"5","key":"46738_CR27","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S1474-4422(18)30053-X","volume":"17","author":"SJ van der Lee","year":"2018","unstructured":"van der Lee, S. J. et al. The effect of APOE and other common genetic variants on the onset of Alzheimer\u2019s disease and dementia: a community-based cohort study. Lancet Neurol. 17 (5), 434\u2013444 (2018).","journal-title":"Lancet Neurol."},{"issue":"1","key":"46738_CR28","doi-asserted-by":"publisher","first-page":"22675","DOI":"10.1038\/s41598-021-01993-x","volume":"11","author":"M Gijs","year":"2021","unstructured":"Gijs, M. et al. Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration. Sci. Rep. 11 (1), 22675 (2021).","journal-title":"Sci. Rep."},{"key":"46738_CR29","doi-asserted-by":"crossref","unstructured":"Chen, Y., Chen, L., Lun, A. T. L., Baldoni, P. L. & Smyth, G. K. edgeR 4.0: powerful differential analysis of sequencing data with expanded functionality and improved support for small counts and larger datasets. bioRxiv 2024:2024.01.21.576131.","DOI":"10.1101\/2024.01.21.576131"},{"key":"46738_CR30","doi-asserted-by":"publisher","first-page":"110231","DOI":"10.1016\/j.exer.2025.110231","volume":"251","author":"S Ahmed","year":"2025","unstructured":"Ahmed, S. et al. Mass spectrometric detection of keratins in tear fluid. Exp. Eye Res. 251, 110231 (2025).","journal-title":"Exp. Eye Res."},{"issue":"3","key":"46738_CR31","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1001\/jamaneurol.2021.5216","volume":"79","author":"WJ Jansen","year":"2022","unstructured":"Jansen, W. J. et al. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurol. 79 (3), 228\u2013243 (2022).","journal-title":"JAMA Neurol."},{"issue":"2","key":"46738_CR32","first-page":"434","volume":"144","author":"A Keshavan","year":"2021","unstructured":"Keshavan, A. et al. Population-based blood screening for preclinical Alzheimer\u2019s disease in a British birth cohort at age 70. Brain 144 (2), 434\u2013449 (2021).","journal-title":"Brain"},{"issue":"D1","key":"46738_CR33","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2015","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44 (D1), D457\u2013D62 (2015).","journal-title":"Nucleic Acids Res."},{"issue":"6220","key":"46738_CR34","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347 (6220), 1260419 (2015).","journal-title":"Science"},{"issue":"5","key":"46738_CR35","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","volume":"1830","author":"SC Lu","year":"2013","unstructured":"Lu, S. C. Glutathione synthesis. Biochimica et Biophysica Acta (BBA) -. Gen. Subj. 1830 (5), 3143\u20133153 (2013).","journal-title":"Gen. Subj."},{"issue":"4","key":"46738_CR36","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1007\/s00415-023-12104-3","volume":"271","author":"E Luib","year":"2024","unstructured":"Luib, E. et al. Reduced tear fluid production in neurological diseases: a cohort study in 708 patients. J. Neurol. 271 (4), 1824\u20131836 (2024).","journal-title":"J. Neurol."},{"issue":"4","key":"46738_CR37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3109\/02713683.2014.930154","volume":"40","author":"N \u00d6rnek","year":"2015","unstructured":"\u00d6rnek, N., Ersel, D. & \u00d6rnek, K. Corneal Sensitivity and Tear Function in Neurodegenerative Diseases. Curr. Eye Res. 40 (4), 423\u2013428 (2015).","journal-title":"Curr. Eye Res."},{"issue":"19","key":"46738_CR38","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2015.4668","volume":"313","author":"WJ Jansen","year":"2015","unstructured":"Jansen, W. J. et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. Jama 313 (19), 1924\u20131938 (2015).","journal-title":"Jama"},{"issue":"1","key":"46738_CR39","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1038\/s41598-022-10793-w","volume":"12","author":"R Lekhraj","year":"2022","unstructured":"Lekhraj, R. et al. Altered abundances of human immunoglobulin M and immunoglobulin G subclasses in Alzheimer\u2019s disease frontal cortex. Sci. Rep. 12 (1), 6934 (2022).","journal-title":"Sci. Rep."},{"key":"46738_CR40","doi-asserted-by":"crossref","unstructured":"Saluri, M. et al. A grappling hook interaction connects self-assembly and chaperone activity of Nucleophosmin 1. PNAS Nexus ;2(2). (2023).","DOI":"10.1093\/pnasnexus\/pgac303"},{"issue":"6451","key":"46738_CR41","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1126\/science.aaw9157","volume":"365","author":"F Frottin","year":"2019","unstructured":"Frottin, F. et al. The nucleolus functions as a phase-separated protein quality control compartment. Science 365 (6451), 342\u2013347 (2019).","journal-title":"Science"},{"key":"46738_CR42","doi-asserted-by":"crossref","unstructured":"Shen, J. et al. Multi-tissue proteomic signatures of Alzheimer\u2019s disease: a systematic investigation in brain, CSF, blood and an exploratory study in tears. medRxiv 2025:2025.01.14.25320538.","DOI":"10.1101\/2025.01.14.25320538"},{"issue":"2","key":"46738_CR43","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1021\/pr9006365","volume":"9","author":"DL Tabb","year":"2010","unstructured":"Tabb, D. L. et al. Repeatability and Reproducibility in Proteomic Identifications by Liquid Chromatography\u2013Tandem Mass Spectrometry. J. Proteome Res. 9 (2), 761\u2013776 (2010).","journal-title":"J. Proteome Res."},{"key":"46738_CR44","doi-asserted-by":"crossref","unstructured":"Hawkridge, A. M. in Practical Considerations and Current Limitations in Quantitative Mass Spectrometry-based Proteomics. 0 (eds Eyers, C. E. & Gaskell, S.) (The Royal Society of Chemistry, 2014).","DOI":"10.1039\/9781782626985-00001"},{"issue":"4","key":"46738_CR45","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","volume":"57","author":"R Wang","year":"2017","unstructured":"Wang, R. & Reddy, P. H. Role of Glutamate and NMDA Receptors in Alzheimer\u2019s Disease. J. Alzheimers Dis. 57 (4), 1041\u20131048 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"46738_CR46","doi-asserted-by":"publisher","first-page":"102690","DOI":"10.1016\/j.redox.2023.102690","volume":"62","author":"Y Sun","year":"2023","unstructured":"Sun, Y. et al. Promotion of astrocyte-neuron glutamate-glutamine shuttle by SCFA contributes to the alleviation of Alzheimer\u2019s disease. Redox Biol. 62, 102690 (2023).","journal-title":"Redox Biol."},{"issue":"8","key":"46738_CR47","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s11064-012-0755-8","volume":"37","author":"C Venkateshappa","year":"2012","unstructured":"Venkateshappa, C., Harish, G., Mahadevan, A., Srinivas Bharath, M. M. & Shankar, S. K. Elevated Oxidative Stress and Decreased Antioxidant Function in the Human Hippocampus and Frontal Cortex with Increasing Age: Implications for Neurodegeneration in Alzheimer\u2019s Disease. Neurochem. Res. 37 (8), 1601\u20131614 (2012).","journal-title":"Neurochem. Res."},{"issue":"10","key":"46738_CR48","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.biopsych.2015.04.005","volume":"78","author":"PK Mandal","year":"2015","unstructured":"Mandal, P. K., Saharan, S., Tripathi, M. & Murari, G. Brain Glutathione Levels \u2013 A Novel Biomarker for Mild Cognitive Impairment and Alzheimer\u2019s Disease. Biol. Psychiatry. 78 (10), 702\u2013710 (2015).","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"46738_CR49","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3174\/ajnr.A5143","volume":"38","author":"GC Chiang","year":"2017","unstructured":"Chiang, G. C. et al. Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with <\u2009sup>1\u2009H-MRS and Pittsburgh Compound-B PET. Am. J. Neuroradiol. 38 (6), 1130\u20131137 (2017).","journal-title":"Am. J. Neuroradiol."},{"issue":"1","key":"46738_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13195-022-00961-5","volume":"14","author":"JJ Chen","year":"2022","unstructured":"Chen, J. J. et al. Altered central and blood glutathione in Alzheimer\u2019s disease and mild cognitive impairment: a meta-analysis. Alzheimers Res. Ther. 14 (1), 23 (2022).","journal-title":"Alzheimers Res. Ther."},{"issue":"3","key":"46738_CR51","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF03159937","volume":"14","author":"JD Adams","year":"1991","unstructured":"Adams, J. D., Klaidman, L. K., Odunze, I. N., Shen, H. C. & Miller, C. A. Alzheimer\u2019s and Parkinson\u2019s disease. Mol. Chem. Neuropathol. 14 (3), 213\u2013226 (1991).","journal-title":"Mol. Chem. Neuropathol."},{"key":"46738_CR52","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.exer.2016.05.027","volume":"156","author":"JC Lim","year":"2017","unstructured":"Lim, J. C., Umapathy, A., Grey, A. C., Vaghefi, E. & Donaldson, P. J. Novel roles for the lens in preserving overall ocular health. Exp. Eye Res. 156, 117\u2013123 (2017).","journal-title":"Exp. Eye Res."},{"issue":"1","key":"46738_CR53","doi-asserted-by":"publisher","first-page":"8507","DOI":"10.1038\/s41598-020-65503-1","volume":"10","author":"F Maass","year":"2020","unstructured":"Maass, F. et al. Increased alpha-synuclein tear fluid levels in patients with Parkinson\u2019s disease. Sci. Rep. 10 (1), 8507 (2020).","journal-title":"Sci. Rep."},{"issue":"2","key":"46738_CR54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.14802\/jmd.24014","volume":"17","author":"M Gijs","year":"2024","unstructured":"Gijs, M. et al. High Levels of Mutant Huntingtin Protein in Tear Fluid From Huntington\u2019s Disease Gene Expansion Carriers. J. Mov. Disord. 17 (2), 181\u2013188 (2024).","journal-title":"J. Mov. Disord"},{"issue":"11","key":"46738_CR55","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2217\/bmm-2019-0167","volume":"13","author":"SF Hamm-Alvarez","year":"2019","unstructured":"Hamm-Alvarez, S. F. et al. Oligomeric \u03b1-synuclein is increased in basal tears of Parkinson\u2019s patients. Biomark. Med. 13 (11), 941\u2013952 (2019).","journal-title":"Biomark. Med."},{"issue":"1","key":"46738_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrg3356","volume":"14","author":"AFM Altelaar","year":"2013","unstructured":"Altelaar, A. F. M., Munoz, J. & Heck, A. J. R. Next-generation proteomics: towards an integrative view of proteome dynamics. Nat. Rev. Genet. 14 (1), 35\u201348 (2013).","journal-title":"Nat. Rev. Genet."},{"issue":"D1","key":"46738_CR57","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol, Y. et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 53 (D1), D543\u2013d53 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46738-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46738-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46738-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:03:20Z","timestamp":1780484600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46738-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46738"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46738-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The medical ethics committee of the Maastricht University Medical Center+, the Netherlands approved the TearAD study (identifier: NL73600.068.20\/METC 20\u2013033), and all participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"17143"}}